CPRX - catalystpharma.com Uzoq muddatli majburiyatlarning kapitalga nisbati
Patrick McAnany rahbarligida Catalyst Pharmaceuticals (CPRX) kam uchraydigan mushak patologiyalari uchun davolash usullarini ishlab chiqmoqda va GURU.Markets grafigidagi separate_debt_long_eq metriki bo'yicha chiziqli narx harakati 0.00 ni tashkil etadi. Biznes, FDA ning qat'iy nazoratiga qaramay, qat'iy patent himoyasi va kamyob kasalliklar dori vositalari sektoridagi ta'sirga tayanadi. Sotuvlar barqarorligi no-tsiklik talab va mahsulotlarning terapevtik imkoniyatlari kengayishi bilan ta'minlanmoqda.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CPRX_-_Catalyst-Pharmaceuticals_-_Long-Term-Debt-to-Equity-Ratio "CPRX: Catalyst Pharmaceuticals, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 25.07.2026 | 👁️GURU.Markets👁️")
Catalyst Pharmaceuticals (CPRX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Catalyst Pharmaceuticals|CPRX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati catalystpharma.com|CPRX - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Catalyst Pharmaceuticals, Inc.|CPRX - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Catalyst Pharmaceuticals
Kompaniyaning jamlanma tahlili:CPRX Catalyst Pharma
Catalyst Pharmaceuticals (CPRX) moliyaviy barqarorligini baholash defolt xatarlarini bartaraf etish uchun qarzning kapitalga nisbati tahlilini talab qiladi. Kamyob kasalliklar dori vositalari ta'minot zanjirlarining barqarorligi operatsion uzilishlarni minimallashtiradi va kompaniyaga uzoq muddatli majburiyatlarni samarali tarzda bajarish imkonini beradi. Uzoq muddatli qarzning kapitalga nisbati bo'yicha ushbu grafik muddati bir yildan ortiq bo'lgan kreditlar ulushini aks ettiradi va biznesning tashqi moliyalashtirishga bog'liqlik darajasini belgilaydi.
Asosiy raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Denali Corp (DNLI) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati HRMY|Uzoq muddatli qarzning o'z kapitaliga nisbati biohavenpharma.com|Uzoq muddatli qarzning kapitalga nisbati AMLX|Uzoq muddatli qarzning kapitalga nisbati Trevi Therapeutics Inc TRVI|Uzoq muddatli qarzning o'z kapitaliga nisbati Praxis Medicines (PRAX)|Uzoq muddatli kreditlarning kapitalga nisbati Anavex Life Sciences Corp AVXL|CeriBell, Inc. - Uzoq muddatli qarzning kapitalga nisbati|PRTA: Uzoq muddatli qarzning kapitalga nisbati|alector.com (ALEC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Biosciences|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER (Omeros Corp)|Uzoq muddatli majburiyatlarning kapitalga nisbati NGNE|ACIU (AC Immune) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati voyagertherapeutics.com VYGR|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics, Inc. (NMRA)|SCLX - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Tevogen Bio Holdings, Inc. (TVGN)|ACOG: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Cognition Therapeutics (CGTX)|inhibikase.com (IKT) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|SAVA - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Assertio Therapeutics|Uzoq muddatli qarzning kapitalga nisbati COYA|Uzoq muddatli qarzning kapitalga nisbati VTGN (vistagen.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics|acumenpharm.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CRVO: Uzoq muddatli qarzning o'z kapitaliga nisbati|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLNN: Uzoq muddatli qarzning kapitalga nisbati|PepGen (PEPG) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati JUNS|Uzoq muddatli qarzning o'z kapitaliga nisbati relmada.com|Annovis Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati gracetx.com GRCE|Uzoq muddatli qarzning o'z kapitaliga nisbati AIFF (Firefly Neuroscience Inc)|KLTO - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroSense Therapeutics, Ltd. NRSN|RVPH - Uzoq muddatli kreditlarning kapitalga nisbati|metaviatx.com - Uzoq muddatli qarzning kapitalga nisbati|NeurAxis Inc. (NRXS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati HSDT|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio Corp|Uzoq muddatli qarzning kapitalga nisbati NEUP|Uzoq muddatli qarzning kapitalga nisbati NERV (minervaneurosciences.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|Addex Therapeutics Ltd. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ALZN (Alzamend)|CYCN - Uzoq muddatli qarzdorlikning kapitalga nisbati|PTIX (protagenic.com) - Uzoq muddatli qarzning kapitalga nisbati|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc CRGT|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati ATXI|Brainstorm Cell Therapeutics, Inc. (BCLI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Cara Therapeutics Inc CARA|CHRO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Eliem Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Intra-Cellular (ITCI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati MRNS|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SAGE|Synaptogenix (SNPX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TRVN (Trevena Inc.)|VIGL: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Anew Medical Inc. WENA|CERE: Uzoq muddatli qarzning kapitalga nisbati